Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Randomised, DBPC, Double-dummy, Multicenter CT of Efficacy and Safety With IT in Patients With Controlled Mild to Moderate Allergic Asthma and Rhinitis/Rhinoconjunctivitis, Allergic to D. Pteronyssinus and/or D. Farinae.

NCT05400811 is registered in ClinicalTrials.gov with Inmunotek S.L. as lead sponsor.

NCT NCT05400811
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05400811 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Randomised, DBPC, Double-dummy, Multicenter CT of Efficacy and Safety With IT in Patients With Controlled Mild to Moderate Allergic Asthma and Rhinitis/Rhinoconjunctivitis, Allergic to D. Pteronyssinus and/or D. Farinae.
Lead sponsor
Inmunotek S.L.
Phase
Phase 3
Overall status
Unknown status
Start date
December 31, 2022
Completion date
July 31, 2025
Enrollment
400 (estimated)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

allergic asthma, allergic rhinoconjunctivitis, house dust mite allergy, perennial allergic rhinitis